TrialThe New England journal of medicine2012
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
752 papers cite itlatest 60 shown
this paperpooled ittrialcites it